샘플 요청 목록

 카트 문의
시장보고서
상품코드
1555536

의약품 현탁액 시장 : 유형별, 적응증별, 최종 사용자별, 국가별, 지역별 - 산업 분석, 시장 규모, 시장 점유율 예측(2024-2032년)

Pharmaceutical Suspension Market, By Type, By Indication, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 392 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

보고서 하이라이트

의약품 현탁액 시장 규모는 2023년 563억 4,532만 달러로 2024-2032년 연평균 복합 성장률(CAGR) 4.3%로 확대

의약품 현탁액 시장 - 시장 역학

약물전달 기술의 진보와 R&D 투자 증가가 시장 수요를 촉진할 전망

약물 전달 시스템 및 제제 기술의 혁신은 현탁액의 효능과 안정성을 향상시킵니다. 안정적이고 고품질의 현탁 제제를 제조하는 기술의 향상은 복잡한 약제의 요구를 충족시키는 데 도움이되고 시장 성장을 뒷받침합니다. 당뇨병, 암, 호흡기 질환 등의 만성 질환 증가에 의해 현탁제를 포함한 다양한 의약품 제제 수요가 높아지고 있습니다. 이 제형은 액체 약제가 필요한 환자에게 특히 유용합니다. 게다가, 보다 우수한 혼합·분쇄 기술 등의 제조 공정의 진보는 의약품 현탁액의 품질과 일관성을 향상시켜, 제조자와 소비자 모두에게 보다 매력적인 것이 되고 있습니다.

제약 회사에 의해 새롭게 개선된 제형을 생산하기 위한 R&D 투자 증가는 시장 성장을 가속합니다. 여기에는 신약용 현탁액의 개발과 기존 제품의 개선이 포함됩니다. 게다가 제산제, 기침 시럽, 진통제 등 현탁액 형태의 일반용 의약품(OTC) 수요는 편리하고 이용하기 쉬운 치료를 선호하는 소비자의 취향에 밀려 늘어나고 있습니다.

의약품 현탁액 시장 - 주요 인사이트

우리의 리서치 애널리스트의 분석에 따르면 세계 시장은 예측 기간(2024-2032년)에 약 4.3%의 연평균 복합 성장률(CAGR)로 연간 성장할 것으로 예측되고 있습니다.

유형별 세분화를 기반으로 비경구 부문은 약물전달를 위한 빠르고 직접적인 경로를 통해 2023년에 가장 큰 시장 점유율을 보여줄 것으로 예측됩니다.

적응증별로는 항암제의 입수 가능성이 높기 때문에 2023년에는 암 영역이 주요 적응증이 되었습니다.

최종사용자별로는 암이나 만성질환의 유병률 증가로 2023년에는 병원이 주요 최종사용자가 되었습니다.

지역별로는 현탁액 기반 의약품이 널리 이용 가능하기 때문에 북미는 2023년 수익으로 선도했습니다.

의약품 현탁액 시장 - 세분화 분석 :

의약품 현탁액 세계 시장은 유형, 적응증, 최종 사용자 및 지역에 따라 세분화됩니다.

시장은 유형에 따라 경구, 비경구 및 기타 세 가지로 분류됩니다. 비경구제가 시장을 독점하고 있습니다. 비경구 제제의 진보와 채용 확대는 주로 시장 성장을 뒷받침하고 있습니다.

시장은 적응증별로 암, 소화기, 신경, 감염증 등 5가지로 분류됩니다. 암 분야는 시장을 독점하고 있습니다. 치료 영역과 기술의 개발이 진행되고 있는 것이 이 분야의 성장을 자극하고 있습니다.

최종 사용자별로는 병원, 클리닉, 기타로 분류됩니다. 병원 분야가 시장을 독점하고 있으며 예측 기간 동안 높은 우위를 유지할 것으로 예상됩니다. 만성 질환 치료 및 치료 개선은 이 분야의 성장을 가속하고 있습니다.

의약품 현탁액 시장 - 지리적 통찰

지역적으로, 이 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카으로 퍼져 있습니다. 아시아태평양은 인구가 많고 건강 관리 지출이 증가하고 만성 질환의 유병률이 증가함에 따라 주요 시장이되었습니다. 이 지역에는 중국, 인도, 일본 등 의약품 제조의 중요한 거점이 되는 국가가 있습니다. 중동 및 아프리카 시장은 다른 지역에 비해 상대적으로 발전도상이지만, 헬스케어에의 액세스가 향상되어, 다양한 치료 옵션에 대한 인식이 높아지고 있기 때문에 관심이 높아지고 있습니다.

의약품 현탁액 시장 - 경쟁 구도:

의약품 현탁액 시장은 지속적인 진보와 경쟁 전략이 그 진화를 형성하고 있으며 현저하게 역동적입니다. 기술 혁신과 전략적 파트너십을 활용하는 기업 주요 기업들은 자사 제품을 차별화하고 경쟁력을 유지하기 위해 기술 혁신에 주력하고 있습니다. 여기에는 새로운 제제 개발, 약물 전달 시스템 개선, R&D 투자 등이 포함됩니다. 기업은 종종 학술기관과 연구기관과 협력하여 약물전달의 과학을 발전시키고 혁신적인 현탁 제제를 개발하고 있습니다.

2023년 8월 세계 바이오 의약품의 주요 기업인 Merck는 자이르 에볼라 바이러스라는 질병에 대한 ERVEBO의 적응 확대 승인을 발표했습니다.

2023년 11월, eva Pharmaceutical Industries와 Royalty Pharma plc가 제휴하여 임상 연구 프로그램을 가속했습니다.

목차

제1장 의약품 현탁액 시장 개요

  • 조사 범위
  • 시장추정년

제2장 주요 요약

  • 시장 분석
  • 경쟁 인사이트

제3장 의약품 현탁액의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 미래 동향

제4장 의약품 현탁액 산업의 조사

  • PEST 분석
  • Porter's Five Forces 분석
  • 성장 전망 맵핑
  • 규제 틀 분석

제5장 의약품 현탁액 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 의약품 현탁액 시장 상황

  • 의약품 현탁액 시장 점유율 분석, 2023년
  • 주요 제조업체별 분석 데이터
    • 기존 기업의 분석
    • 신흥기업의 분석

제7장 의약품 현탁액 시장-유형별

  • 개요
    • 부문 점유율 분석
    • 경구
    • 비경구
    • 기타

제8장 의약품 현탁액 시장-적응증별

  • 개요
    • 부문 점유율 분석
    • 암
    • 위장
    • 신경학적
    • 감염증
    • 기타

제9장 의약품 현탁액 시장 - 최종 사용자별

  • 개요
    • 부문 점유율 분석
    • 병원
    • 클리닉
    • 기타

제10장 의약품 현탁액 시장-지역별

  • 소개
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 - 의약품 현탁액 업계

  • 경쟁 대시보드
  • 기업 프로파일
    • Pfizer Inc.
    • Johnson &Johnson
    • Novartis AG
    • GlaxoSmithKline(GSK)
    • Sanofi
    • Roche
    • Merck &Co., Inc.
    • Bristol-Myers Squibb
    • AbbVie Inc.
    • AstraZeneca
    • Amgen Inc.
    • Glenmark Pharmaceuticals
    • Teva Pharmaceutical Industries Ltd.
    • Mylan NV
    • Dr. Reddy's Laboratories
    • Others

제12장 애널리스트의 전방위 전망

JHS 24.10.10

REPORT HIGHLIGHT

Pharmaceutical Suspension Market size was valued at USD 56,345.32 Million in 2023, expanding at a CAGR of 4.3% from 2024 to 2032.

A pharmaceutical suspension is a type of liquid dosage form used in medicine. It consists of solid particles dispersed throughout a liquid medium. Unlike solutions where the active ingredient is fully dissolved, in suspensions, the active ingredient remains undissolved and is suspended in the liquid.

Pharmaceutical Suspension Market- Market Dynamics

Advancement in drug delivery technologies and increasing R&D investment is expected to propel market demand

Innovations in drug delivery systems and formulation technologies enhance the efficacy and stability of suspensions. Improved technologies for creating stable, high-quality suspensions help meet the needs of complex medications, which is boosting market growth. The increasing incidence of chronic conditions such as diabetes, cancer, and respiratory diseases drives the demand for various pharmaceutical formulations, including suspensions. These formulations are particularly useful for patients who need medication in a liquid form. Further, Advances in manufacturing processes, such as better mixing and milling techniques, improve the quality and consistency of pharmaceutical suspensions, making them more attractive to both manufacturers and consumers.

Increased investment in research and development by pharmaceutical companies to create new and improved formulations drives market growth. This includes developing suspensions for new drugs or improving existing products. Moreover, the demand for over the counter (OTC) medications in suspension form, such as antacids, cough syrups, and pain relievers, continues to grow, driven by consumer preference for convenient and accessible treatments.

Pharmaceutical Suspension Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.3% over the forecast period (2024-2032)

Based on Type segmentation, the parenteral segment was predicted to show maximum market share in the year 2023, owing to its rapid & direct route for drug delivery.

Based on Indication segmentation, the cancer segment was the leading Indication in 2023, owing to the large availability of cancer drugs.

Based on End User segmentation, the hospitals segment was the leading End User segment in 2023, owing to the increasing prevalence of cancer, chronic disorders.

Based on region, North America was the leading revenue generator in 2023, due to the wide availability of suspension-based medications.

Pharmaceutical Suspension Market- Segmentation Analysis:

The Global Pharmaceutical Suspension Market is segmented based on Type, Indication, End User, and Region.

The market is divided into three categories based on Type: oral, parenteral, and others. The parenteral segment dominates the market. Advancements in parenteral drug formulations and their greater adoption are mainly boosting market growth.

The market is divided into five categories based on Indication: cancer, gastrointestinal, neurological, infectious disease, and others. The cancer segment dominates the market. The growing development in therapeutic areas and technology is stimulating segment growth.

The market is divided into three categories based on End Users: hospitals, clinics, and others. The hospital segment dominates the market and is expected to maintain its high dominance during the forecast period. The improved chronic disease treatment and therapy are proliferating segment growth.

Pharmaceutical Suspension Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Asia Pacific is a major market due to its large population, rising healthcare expenditure, and increasing prevalence of chronic diseases. The region has countries like China, India, and Japan which are significant hubs for pharmaceutical manufacturing. The Middle East & Africa market is relatively underdeveloped compared to other regions, but there is growing interest due to increasing healthcare access and rising awareness of various treatment options.

Pharmaceutical Suspension Market- Competitive Landscape:

The pharmaceutical suspension market is significantly dynamic, with ongoing advancements and competitive strategies shaping its evolution. Companies that leverage technological innovation, and strategic partnerships. Leading companies focus on innovation to differentiate their products and maintain a competitive edge. This includes developing new formulations, improving drug delivery systems, and investing in research and development. Companies often collaborate with academic institutions and research organizations to advance the science of drug delivery and develop innovative suspension formulations.

In August 2023, Merck & Co., Inc., a leading global biopharmaceutical company, announced the approval of an expanded indication for ERVEBO for the disease called Zaire ebolavirus.

In November 2023, Teva Pharmaceutical Industries and Royalty Pharma plc, partnered to accelerate their clinical research program.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PHARMACEUTICAL SUSPENSION MARKET KEY PLAYERS

  • Pfizer Inc.
  • Johnson & Johnson
  • Novartis AG
  • GlaxoSmithKline (GSK)
  • Sanofi
  • Roche
  • Merck & Co., Inc.
  • Bristol-Myers Squibb
  • AbbVie Inc.
  • AstraZeneca
  • Amgen Inc.
  • Glenmark Pharmaceuticals
  • Teva Pharmaceutical Industries Ltd.
  • Mylan N.V.
  • Dr. Reddy's Laboratories
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY TYPE- MARKET ANALYSIS, 2019-2032

  • Oral
  • Parenteral
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Cancer
  • Gastrointestinal
  • Neurological
  • Infectious Disease
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics
  • Others

GLOBAL PHARMACEUTICAL SUSPENSION MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Pharmaceutical Suspension Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Pharmaceutical Suspension Market Snippet by Type
    • 2.1.2. Pharmaceutical Suspension Market Snippet by Indication
    • 2.1.3. Pharmaceutical Suspension Market Snippet by End User
    • 2.1.4. Pharmaceutical Suspension Market Snippet by Country
    • 2.1.5. Pharmaceutical Suspension Market Snippet by Region
  • 2.2. Competitive Insights

3. Pharmaceutical Suspension Key Market Trends

  • 3.1. Pharmaceutical Suspension Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Pharmaceutical Suspension Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Pharmaceutical Suspension Market Opportunities
  • 3.4. Pharmaceutical Suspension Market Future Trends

4. Pharmaceutical Suspension Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Pharmaceutical Suspension Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Pharmaceutical Suspension Market Landscape

  • 6.1. Pharmaceutical Suspension Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Pharmaceutical Suspension Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Oral
    • 7.1.3. Parenteral
    • 7.1.4. Others

8. Pharmaceutical Suspension Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 8.1.2. Cancer
    • 8.1.3. Gastrointestinal
    • 8.1.4. Neurological
    • 8.1.5. Infectious Disease
    • 8.1.6. Others

9. Pharmaceutical Suspension Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Pharmaceutical Suspension Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Pharmaceutical Suspension Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Pharmaceutical Suspension Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Pharmaceutical Suspension Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Pharmaceutical Suspension Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Pharmaceutical Suspension Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Pharmaceutical Suspension Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Pfizer Inc.
    • 11.2.2. Johnson & Johnson
    • 11.2.3. Novartis AG
    • 11.2.4. GlaxoSmithKline (GSK)
    • 11.2.5. Sanofi
    • 11.2.6. Roche
    • 11.2.7. Merck & Co., Inc.
    • 11.2.8. Bristol-Myers Squibb
    • 11.2.9. AbbVie Inc.
    • 11.2.10. AstraZeneca
    • 11.2.11. Amgen Inc.
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Teva Pharmaceutical Industries Ltd.
    • 11.2.14. Mylan N.V.
    • 11.2.15. Dr. Reddy's Laboratories
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제